comprehensive
Previous article:
Psychedelics group wrestles with new pharma identity
Next article: 'Screen and refer' systems are hurting patients
Next article: 'Screen and refer' systems are hurting patients
hotspot
focus
-
Security flaws in third
2025-09-01 14:04 -
BioAge raises $170M for combination therapy with Zepbound
2025-09-01 14:03 -
Doctors' information doesn't help them choose wisely when sick
2025-09-01 14:00 -
Drug cartel violence flares in western Mexico after vigilante leader's killing
2025-09-01 13:52 -
Drug cartel violence flares in western Mexico after vigilante leader's killing
2025-09-01 13:35 -
Vertex cell therapy lets patients with type 1 diabetes stop insulin
2025-09-01 12:57